bioRxivBioengineering
Human Retina-on-a-Chip: Merging Organoid and Organ-on-a-Chip Technology to Generate Complex Multi-Layer Tissue Models
K. Achberger, C. Probst, J. Haderspeck, S. Bolz, J. Rogal, J. Chuchuy, M. Nikolova, V. Cora, L. Antkowiak, W. Haq, N. Shen, K. Schenke-Layland, M. Ueffing, S. Liebau, P. Loskill
Abstract
The devastating effects and incurable nature of hereditary and sporadic retinal diseases such as Stargardt disease, age-related macular degeneration or retinitis pigmentosa urgently require the development of new therapeutic strategies. Additionally, the prevalence of retinal toxicities is becoming more and more an issue of novel targeted therapeutic agents. To date, (ophthalmologic) drug development largely relies on animal models. Inadequate translatability of results from animal models to humans, however, limits advances in drug development and discovery. Hence, the establishment of more relevant human tissue-based in vitro models is of upmost importance. The discovery of self-forming retinal organoids (ROs) derived from human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) is a promising approach to model the complex stratified retinal tissue. Yet, ROs lack vascularization and cannot recapitulate the important physiological interactions of matured photoreceptors and the retinal pigment epithelium (RPE). In this study, we present the retina-on-a-chip (RoC), a novel microphysiological model of the human retina integrating more than seven different essential retinal cell types derived from hiPSCs in a vasculature-like perfusion and enabling, for the first time, the recapitulation of the interaction of mature photoreceptor segments with RPE in vitro. We show that this interaction enhances the formation of outer segment like-structures and the establishment of in vivo-like physiological processes such as outer segment phagocytosis and calcium dynamics. In addition, we demonstrate the applicability of the RoC for drug testing, by reproducing the retinopathic side effects of the anti-malaria drug chloroquine and the antibiotic gentamicin. The developed hiPSC-based RoC has the potential to promote drug development and provide new insights into the underlying pathology of retinal diseases.
- organism: human
- assay: organoid / primary culture
- research focus: drug response / drug discovery
- research focus: cell type annotation
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- 3D-printed microfluidic chip for modeling retinal organoid-endothelial co-culture
Rodi Abdalkader, Shigeru Kawakami, … Takuya Fujita·bioRxiv·Sep 26, 2025
- Human stem cell-based retina-on-chip as new translational model for validation of AAV retinal gene therapy vectors
K. Achberger, M. Cipriano, … P. Loskill·bioRxiv·Mar 2, 2021
- Electroporation-Based Gene Delivery and Whole-Organoid Imaging in Human Retinal Organoids
Keevon Flohr, Michael Janeček, … Susana da Silva·Developmental BiologyPeer-reviewed·Dec 4, 2025
- Transient Vascular Cell Integration and Intrinsic Media-Stimulated Endothelial Activation Reveal Diabetic Retinopathy Signatures in Human Retinal Organoids
Rozaliya Tsikandelova, Raphael Schettler, … Majlinda Lako·bioRxiv·Oct 8, 2026
- 3D human retinal organoid model for the study of early diabetic retinopathy
Luísa de Lemos, Pedro Antas, … Sandra Tenreiro·bioRxiv·Sep 4, 2023
- Integrating human iPSC-derived macrophage progenitors into retinal organoids to generate a mature retinal microglial niche
A. Usui-Ouchi, S. Giles, … K. T. Eade·bioRxiv·Dec 23, 2022